Leo Pharma’s Anzupgo (Delgocitinib Cream) Scores Marketing Approval for CHE in Switzerland
Swissmedic, Switzerland’s national regulatory agency for therapeutic products, has granted marketing approval to Leo Pharma’s Anzupgo (delgocitinib cream) for the treatment of moderate to severe Chronic Hand Eczema (CHE) in adults who have had an inadequate response to topical corticosteroids, or for whom potent to very potent topical corticosteroids are not advisable. Delgocitinib cream is the first […]